Effects of combined use of diallyl disulfide and N-acetyl-cysteine on acetaminophen hepatotoxicity in β-naphthoflavone-pretreated mice

World Journal of Gastroenterology

Volumn 4, Issue 1-6, 1998, Pages 112-116

  Zhao, Cong ^a,b   Duquet, Sheryl ^b   Zhou, Yiao Xia ^a  

^a Third People's Hospital of Chengdu   (China)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

7 alkoxycoumarin O dealkylase; Acetaminophen; Beta naphthoflavone; Diallyl disulfide; Glutathione; Liver drug effects; N acetyl cysteine

Indexed keywords

EID: 0007837234     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v4.i2.112     Document Type: Article

References (18)

1. Miner DJ, Kissinger PT. Evidence for the involvement of N-acetyl-p-quinoneimine in acetaminophen metabolism. Biochem Pharmacol, 1979;28:3285-3290
2. Hurman AW, Kyle ME, Serroni A, Farber JL. The killing of cultured hepatocytes by N-acetyl-p-benzoquinoneimine (NAPQI) as a model of the cytotoxicity of acetaminophen. Biochem Pharmacol, 1991;41(8):1111-1117
3. Miller MR, Wentz E, Blair JB, Pack D, Hinton DE. Acetaminophen toxicity in cultured trout liver cells. Experiment Molecul Pathol, 1993;58:114-126
4. Roberts WD, Bucci TJ, Benson RW, Warbritton AR, McRae TA, Pumford NR et al. Immunohistochemical localization and quantification of the 3-(cystein-S-yl)-acetaminophen protein adduct in acetaminophen hepatotoxicity. Am J Pathol, 1991;138(2),359-371
5. Birge RB, Bulera SJ, Banolone JB, Ginsberg GL, Cohen SD, Khairallah EA. The arylation of microsomal membrane proteins by acetaminophen is associated with the release of a 44 kDa acetaminophen-binding mouse liver protein complex into the cytosol. Taric Applied Pharmacol, 1991;109:443-454
6. Holtzman JL. The role of ravalent binding to microsomal proteins in the hepatotoxicity of acetaminophen. Drug Met Rev, 1995;25:395-451
7. Esterline RL, Ray SD, Ji S. Reversible and irreversible inhibition of hepatic mitochondrial respiration by acetaminophen and its toxic metabolite, N-acetyl-p-benzoquinoneimine (NAPQI). Biochem Pharmacol, 1989;38:2387-2390
8. Donnelly PJ, Walker RM, Racz WJ. Inhibition of mitochondrial respiration in vivo is an early event in acetaminophen-induced hepatotoxicity. Arch Toxicol, 1994;68:110-118
9. Harvison PJ, Guengerich FP, Rashed MS, Nelson SD. Cytochrome P450 isozyme selectivity in the oxidation of acetaminophen. Chem Res Toxicol, 1988;1:47-52
10. Lee CA, Thummel KE, Kalhorn TF, Nelson SD, Slattery JT. Inhibition and activation of acetaminophen reactive metabolite formation by caffeine: roles of cytochiome P450 1A1 and 3A2. Drug Metab Disp, 1991;19:348-353
11. Pezzano M, Richard CH, Lampl E, Pelletier G, Fabre M, Rimaillho A et al. Hepatic and renal toxicity of paracetamol in chronic alcoholic subjects. La Presse Medicale, 1988;17:21-24
12. Snawder JE, Roe AL, Benson RW, Roberts DW. Loss of CYP2E1 and CYP 1A2 activity as a function of acetaminophen dose: relation to toxicity. Biochem Biophysic Res Commun, 1994;203(1):532-539
13. Hu JJ, Yoo JS, Lin M, Wang EJ, Yang CS. Protective effects of diallyl sulfide on acetaminophen-induced toxicity. Food Chemical Toxicol, 1996;34:963-969
14. Zhao C, Zhou YX. Induction of cytochrome P450 1A1/1A2 in mouse hepatocytes by β-naphthoflavone: an immunocytochemical study. Chin J New Gastroenterol, 1996;4(8):334-335
15. Mitchell JR, Jollow DJ, Potter WZ, Davis DC, Gillette JR, Brode BB. Acetaminopheninduced hepatic necrosis. I. Role of drug metabolism. J Parmacol Exp Ther, 1973;187:185-194
16. Burke MD, Mayer RT. Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metabol Disposition, 1974;2(6):583-588
17. Patten CJ, Thomas PE, Guy PL, Lee ML, Gonzalez FJ, Guengerich FP et al. Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol, 1993;6:511-518
18. Brady JF, Li D, Ishizaki H, Yang CS. Effect of diallyl sulfide on rat liver microsomal nitrosamine metabolism and other monooxygenase activities. Cancer Res, 1988;48:5937-5940